GLP-1 Receptor Agonist Discontinuation Among Patients With Obesity and/or Type 2 Diabetes
UPMC Center for High Value Health Care
Indexed incrossrefdoajpubmed
Abstract
This cohort study examines the prevalence of and factors associated with glucagon-like peptide 1 agonist discontinuation among new users.
Citation impact
169
total citations
- FWCI
- 52.48
- Percentile
- 100%
- References
- 3
Citations per year
Authors
6Topics & keywords
Topics
Keywords
- Discontinuation
- Agonist
- Glucagon-like peptide 1 receptor
- Type 2 diabetes
- Medicine
- Obesity
- Diabetes mellitus
- Endocrinology
No related works found for this paper.